Main > ONCOLOGY (**) > MyeloDysplastic Syndromes *** > Treatment > USA. O. Decitabine+Cedazuridine

---

USA. O. Decitabine+Cedazuridine's subsections
(*) CA/USA Approval: 2020. 07.07.
Company
Company (Marketing)
Patent (Ce); Claims; No.; Etc.
Patent (De); Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2020. 09.15.
TradeMark (De.)
TradeMark (De.+Ce.)
TradeMark (De.+Ce.) Web-Site

USA. O. Decitabine+Cedazuridine's products
This section has no products